Overview

Link Medicine is working to create the first disease-modifying therapies for a range of neurodegenerative diseases, including Alzheimer's, Parkinson's, and other conditions. Current therapies for these conditions provide at best only symptomatic care, and are limited in their effectiveness and duration. New therapies are desperately needed, and successful development of a disease-modifying approach could have a major impact on human health and the cost of treatment.